Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial …

Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

Medication-related osteonecrosis of the jaw (MRONJ), although initially believed to be
exclusively associated with bisphosphonates, has been implicated in recent reports with …

Purpose To investigate the role of oral health, including periodontitis, as a risk factor for
bisphosphonate-associated jaw osteonecrosis (ONJ). Materials and Methods This cross …

Osteonecrosis of the jaw (ONJ) was defined as exposed, necrotic bone in the maxillofacial
region for at least 8 weeks in patients receiving an antiresorptive medication for primary or …

Medication-related osteonecrosis of the jaw (MRONJ) is one of the most interesting diseases
in the field of maxillofacial surgery. In addition to bisphosphonates, the use of antiresorptive …

Objective Bisphosphonate-associated osteonecrosis of the jaws (BP-ONJ) is triggered by
inflammatory processes. Typical trigger factors are periodontal disease, denture pressure …

Osteonecrosis of the jaw in patients treated with bisphosphonates is a relatively rare but well
known complication at maxillofacial units around the world. It has been speculated that the …

PURPOSE: The aim of this prospective hospital-based study was to refine a surgical
protocol for tooth extractions in patients with a history of intravenous use of a potent …

Although osteonecrosis of the jaws (ONJ), a serious complication of antiresorptive
medications, was reported a decade ago, the exact mechanisms of disease pathophysiology …